-
Merck trashes both of its COVID vaccine candidates due to weak clinical data — Big medtech deals keep on turning — Moderna says its COVID-19 vaccine is less effective against the South African variant — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
VCPR
Discussion in 'Pharma Contract Manufacturing - General Discussion' started by Anonymous, Nov 16, 2014 at 10:05 PM.
Tags:
Add Tags